Invus, L.P.

Invus, L.P. is Director & 10% Owner at LEXICON PHARMACEUTICALS, INC./DE (LXRX). They have made 2 open-market trades across 2 companies since 2016, most recently 2017-11-14.

CIK 0001404570

Get an email the next time Invus, L.P. files.Follow for free

Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.

1 open-market purchase totalling $11.1M since 2017, against 1 sale. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
BUFF	87,460,875	$4.7B
LXRX	1,154,140	$1.8M
Total		$4.7B

Shares reported on the most recent Form 4, priced at the 2017-11-14 close.

Get an email the next time Invus, L.P. files

Free account. One email when the next filing comes in.

Follow Invus, L.P. for free

Buy Track Record

Filings1

Only 1 discretionary filing — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.

Sell Track Record

Filings1

Only 1 decision-sell filing — too few to score

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.